What to Know About the Autus Valve for Children

The newly approved device is intended for children with a congenital problem affecting the valve that sends blood toward the lungs.

HealthOctober 5, 20262 min readHow Sureno writes this

The short version

The FDA announced approval of the Autus Size-Adjustable Valve on October 2, 2026, for pediatric patients with congenital pulmonary valve disease. ¹
The implanted device is designed to be enlarged after its placement as a child grows. ¹
The FDA says its inner flaps, known as leaflets, use polymeric material rather than tissue from animals. ¹
The FDA says the design could lessen the need for later open-heart procedures, but does not say it will eliminate them. ¹

What is the Autus valve?

The Autus Size-Adjustable Valve is an implanted valve for children with a congenital condition involving the pulmonary valve. This valve governs blood flow from the heart toward the lungs. The FDA announced its approval on October 2, 2026. ¹

The device is intended to be made larger after it has been implanted, so its size can be adjusted as a child grows. The FDA also identifies it as the first U.S.-approved heart valve with polymeric material in its leaflets, the small flaps that control flow through the valve, rather than animal-derived tissue. ¹

What might the approval mean for families?

A child’s growth can create challenges for implanted devices sized for a smaller body. The FDA says this valve’s adjustable design may mean fewer repeat open-heart operations for some children. That is a possible benefit, not a guarantee for every patient. ¹

The supplied announcement does not include results from studies, explain how the valve is adjusted, or report how long it lasts. It also does not say which patients are suitable. Those details cannot be established from the available source, so the approval announcement alone does not show what will happen in an individual case.

Where is the official information?

The FDA’s announcement, titled “FDA Approves First Heart Valve Designed to Grow with Children,” provides the agency’s description of the device and its approval. It is available on the FDA website. ¹

What we don't know yet

The supplied announcement does not report clinical study results or detail the evidence behind the approval.
It does not explain the adjustment process or state how long the valve is expected to last.
It does not specify how many patients may avoid additional surgery.

Health news without the hype

Sureno Browser shows official health updates on your start page, explained simply.

Get Sureno for Mac

Questions people ask

Who is the Autus valve intended for?

The FDA approved it for pediatric patients with congenital pulmonary valve disease. It is an implanted valve designed to be enlarged after placement as a child grows. ¹

Will the Autus valve prevent another heart operation?

That is not certain. The FDA says the design may reduce the need for repeat open-heart operations, but does not claim it will prevent them for every child. ¹

Sources

FDA Approves First Heart Valve Designed to Grow with Children — U.S. Food and Drug Administration, 2026-10-02

Free tools for this

They run in your browser. Nothing is uploaded and there is nothing to sign up for.

What is my screen resolution?Your screen size, window size and display sharpness.Hours calculatorHours between a start time and an end time, minus a break.